University of Saskatchewan COVID-19 vaccine approved for human clinical trials

VIDO-InterVac

A COVID-19 vaccine developed by the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO) is headed for human clinical trials.



from CBC | Health News https://ift.tt/3pKQ3XJ

Aucun commentaire:

Enregistrer un commentaire